These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20005726)

  • 41. The role of membrane lipids in the induction of macrophage apoptosis by microparticles.
    Huber LC; Jüngel A; Distler JH; Moritz F; Gay RE; Michel BA; Pisetsky DS; Gay S; Distler O
    Apoptosis; 2007 Feb; 12(2):363-74. PubMed ID: 17191114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
    Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure-activity relationship at the C-terminal position.
    Rancourt J; Cameron DR; Gorys V; Lamarre D; Poirier M; Thibeault D; Llinàs-Brunet M
    J Med Chem; 2004 May; 47(10):2511-22. PubMed ID: 15115394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.
    Watkins WJ; Chen JM; Cho A; Chong L; Collins N; Fardis M; Huang W; Hung M; Kirschberg T; Lee WA; Liu X; Thomas W; Xu J; Zeynalzadegan A; Zhang J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3479-83. PubMed ID: 16621550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    Qiu WW; Shen Q; Yang F; Wang B; Zou H; Li JY; Li J; Tang J
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6618-22. PubMed ID: 19846303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystal structures of mouse autocrine motility factor in complex with carbohydrate phosphate inhibitors provide insight into structure-activity relationship of the inhibitors.
    Tanaka N; Haga A; Naba N; Shiraiwa K; Kusakabe Y; Hashimoto K; Funasaka T; Nagase H; Raz A; Nakamura KT
    J Mol Biol; 2006 Feb; 356(2):312-24. PubMed ID: 16375918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors.
    Cheng JF; Mak CC; Huang Y; Penuliar R; Nishimoto M; Zhang L; Chen M; Wallace D; Arrhenius T; Chu D; Yang G; Barbosa M; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3484-8. PubMed ID: 16644218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase.
    Arenz C; Thutewohl M; Block O; Waldmann H; Altenbach HJ; Giannis A
    Chembiochem; 2001 Feb; 2(2):141-3. PubMed ID: 11828438
    [No Abstract]   [Full Text] [Related]  

  • 50. Rational design of new bifunctional inhibitors of type II dehydroquinase.
    Toscano MD; Stewart KA; Coggins JR; Lapthorn AJ; Abell C
    Org Biomol Chem; 2005 Sep; 3(17):3102-4. PubMed ID: 16106291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel high-throughput screening format to identify inhibitors of secreted acid sphingomyelinase.
    Mintzer RJ; Appell KC; Cole A; Johns A; Pagila R; Polokoff MA; Tabas I; Snider RM; Meurer-Ogden JA
    J Biomol Screen; 2005 Apr; 10(3):225-34. PubMed ID: 15809318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases.
    Wen X; Xia J; Cheng K; Zhang L; Zhang P; Liu J; Zhang L; Ni P; Sun H
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5777-82. PubMed ID: 17869102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis and pharmacological activity of novel enantiomerically pure phosphonic acid-based NAALADase inhibitors.
    Ding P; Helquist P; Miller MJ
    Org Biomol Chem; 2007 Mar; 5(5):826-31. PubMed ID: 17315070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of potent beta-secretase (BACE1) inhibitors with P1' carboxylic acid bioisosteres.
    Kimura T; Hamada Y; Stochaj M; Ikari H; Nagamine A; Abdel-Rahman H; Igawa N; Hidaka K; Nguyen JT; Saito K; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2006 May; 16(9):2380-6. PubMed ID: 16481167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biological evaluation of novel PDMP analogues.
    Hillaert U; Boldin-Adamsky S; Rozenski J; Busson R; Futerman AH; Van Calenbergh S
    Bioorg Med Chem; 2006 Aug; 14(15):5273-84. PubMed ID: 16621573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-based optimization of a potent class of arylamide FMS inhibitors.
    Meegalla SK; Wall MJ; Chen J; Wilson KJ; Ballentine SK; Desjarlais RL; Schubert C; Crysler CS; Chen Y; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Illig CR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3632-7. PubMed ID: 18495479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors.
    Koltun DO; Parkhill EQ; Vasilevich NI; Glushkov AI; Zilbershtein TM; Ivanov AV; Cole AG; Henderson I; Zautke NA; Brunn SA; Mollova N; Leung K; Chisholm JW; Zablocki J
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2048-52. PubMed ID: 19249203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Kornhuber J; Tripal P; Reichel M; Terfloth L; Bleich S; Wiltfang J; Gulbins E
    J Med Chem; 2008 Jan; 51(2):219-37. PubMed ID: 18027916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity.
    Yokomatsu T; Murano T; Akiyama T; Koizumi J; Shibuya S; Tsuji Y; Soeda S; Shimeno H
    Bioorg Med Chem Lett; 2003 Jan; 13(2):229-36. PubMed ID: 12482429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.